ADVERTISEMENT
Key Highlights From CPC+CBEx 2023
The Clinical Pathways Congress + Cancer Care Business Exchange (CPC+CBEx) annual meeting, held in Boston, October 6-8, 2023, brought together oncology leaders from across the care continuum in a dynamic forum to discuss persistent challenges in the business of oncology. The conference provided a platform to explore strategies for enhancing cost-efficiency, improving quality, and expanding access to high-quality cancer care. Topics included the role of AI in oncology, challenges in clinical trial recruitment, the impact of vertical integration, trends in industry consolidation, and more.
VIDEO: What the Growth of Medicare Advantage Means for Value-Based Care in Community Oncology
“What you’re going to see here in the future is risk-bearing primary care groups taking on more Medicare Advantage lives, more Medicare lives, and steering those patients away from the hospital. Creating partnerships with those risk-bearing primary care groups moving forward is the future.” In this interview, David Eagleton, senior vice president at Oncology Care Partners, shares his thoughts on the growth of Medicare Advantage and its impact on community oncology practices in providing value-based care.
AI in Cancer Care: Navigating the Current Landscape and Future Possibilities
In this session, a panel of experts delved deep into the present and future implications of artificial intelligence (AI) in cancer care. During the discussion, the speakers shed light on key considerations for leveraging AI effectively in cancer care, emphasizing the importance of discerning data accuracy, the role of human oversight, and the need for comprehensive understanding and utilization of AI-generated insights.
VIDEO: The Future of Cancer Care at Home
“I think when it comes to cancer care at home, one of the most important things is it’s not a question of if we are going to be able to do care in the home or even the treatment in the home. I think it’s a matter of when and who.” In this interview, Dan Nardi, CEO of Reimagine Care, discusses the future of cancer care in the home. Nardi spoke as part of a session titled “Cancer Care at Home: Opportunities, Risks, and How to Prepare.”
Using Clinical Pathways to Reduce Delays in Time to Treatment
Dennis R. Holmes, MD, began his presentation on how clinical pathways can help with delays in time to treatment by highlighting the importance of the “golden hour,” which is the period of time immediately after a trauma patient experiences a serious injury or stroke and appropriate life-saving medical or surgical intervention is needed for survival. Holmes suggested this approach can and should be applied to cancer care, emphasizing the role of clinical pathways in mitigating delays by establishing time benchmarks for each step of the treatment process.
For more highlights, speaker interviews, and in-depth coverage of the conference, visit the conference newsroom.
